Toomes C, James J, Wood A J, Wu C L, McCormick D, Lench N, Hewitt C, Moynihan L, Roberts E, Woods C G, Markham A, Wong M, Widmer R, Ghaffar K A, Pemberton M, Hussein I R, Temtamy S A, Davies R, Read A P, Sloan P, Dixon M J, Thakker N S
Department of Medical Genetics, St. Mary's Hospital, Manchester, UK.
Nat Genet. 1999 Dec;23(4):421-4. doi: 10.1038/70525.
Papillon-Lefèvre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients. Both the deciduous and permanent dentitions are affected, resulting in premature tooth loss. Palmoplantar keratosis, varying from mild psoriasiform scaly skin to overt hyperkeratosis, typically develops within the first three years of life. Keratosis also affects other sites such as elbows and knees. Most PLS patients display both periodontitis and hyperkeratosis. Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset. The PLS locus has been mapped to chromosome 11q14-q21 (refs 7, 8, 9). Using homozygosity mapping in eight small consanguineous families, we have narrowed the candidate region to a 1.2-cM interval between D11S4082 and D11S931. The gene (CTSC) encoding the lysosomal protease cathepsin C (or dipeptidyl aminopeptidase I) lies within this interval. We defined the genomic structure of CTSC and found mutations in all eight families. In two of these families we used a functional assay to demonstrate an almost total loss of cathepsin C activity in PLS patients and reduced activity in obligate carriers.
掌跖角化牙周病综合征,或掌跖角化伴牙周病(PLS,MIM 245000),是一种常染色体隐性疾病,主要由牙医确诊,因为患者患有严重的牙周炎。乳牙列和恒牙列均受影响,导致牙齿过早脱落。掌跖角化症,从轻度银屑病样鳞状皮肤到明显的角化过度不等,通常在生命的头三年出现。角化症也会影响其他部位,如肘部和膝盖。大多数PLS患者同时表现出牙周炎和角化过度。一些患者只有掌跖角化症或牙周炎,在极少数个体中,牙周炎症状较轻且发病较晚。PLS基因座已被定位到11号染色体q14 - q21区域(参考文献7、8、9)。通过对八个小的近亲家庭进行纯合性定位,我们将候选区域缩小到D11S4082和D11S931之间1.2厘摩的区间。编码溶酶体蛋白酶组织蛋白酶C(或二肽基氨基肽酶I)的基因(CTSC)位于该区间内。我们确定了CTSC的基因组结构,并在所有八个家庭中发现了突变。在其中两个家庭中,我们通过功能检测证明PLS患者的组织蛋白酶C活性几乎完全丧失,而在必然携带者中活性降低。